Palbociclib orotate NEW
| Price | Get Latest Price | |
| Package | 5mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Palbociclib orotate | CAS No.: 2757498-64-7 |
| Supply Ability: 10g | Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Palbociclib orotate |
| Description | Palbociclib (PD 0332991) orotate, an orally active selective inhibitor of CDK4 and CDK6, exhibits IC50 values of 11 and 16 nM, respectively. This compound demonstrates potent anti-proliferative effects and induces cell cycle arrest in cancer cells, applicable in research concerning HR-positive, HER2-negative breast cancer, and hepatocellular carcinoma [1] [3] [4]. |
| In vitro | Palbociclib orotate, at concentrations ranging from 0–1 μM over 24 hours, effectively inhibits Ser 795 phosphorylation in MDA-MB-435 cells, demonstrating an IC50 of 0.063 μM, and similarly impacts Ser 780 and Ser 795 phosphorylation in Colo-205 colon carcinoma cells [1]. At a wider concentration range of 0–10 μM for the same duration, it induces a G1 phase cell cycle arrest in MDA-MB-453 cells [1]. When administered at 500 nM for seven days, palbociclib orotate upregulates homologous gene expression (H2d1, H2k1, and B2m) in both MDA-MB-453 and MDA-MB-361 cells [2]. Additionally, with extended exposure of six days, palbociclib orotate suppresses the growth of various luminal ER-positive and HER2-amplified breast cancer cell lines, with IC50 values spanning from 4 nM to 1 μM [3]. Over a three-day period, it also limits the proliferation of human liver cancer cell lines with IC50 values between 0.01 μM and 3.49 μM and causes reversible cell cycle arrest [4]. |
| In vivo | Palbociclib orotate, administered orally at doses of 75 or 150 mg/kg daily for 14 days, induces rapid tumor regression and impedes tumor growth [1]. At a dose of 90 mg/kg for 12 days, it also decreases Treg cell quantities and alters the Treg:CD8 ratio in the spleen and lymph nodes of tumor-free mice, highlighting its tumor-independent actions [2]. Furthermore, when given at 100 mg/kg for a week, palbociclib orotate exhibits potent anti-tumor effects in a genetically engineered mosaic mouse model of liver cancer [4]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Inhibitors Related | Ribociclib | (E)-β-Farnesene | Amantadine | 2-Chloropyrazine | Kojic acid | Abemaciclib | 2,4,6-Trihydroxybenzoic acid | Palbociclib | Abemaciclib methanesulfonate | Sodium Oxamate | Seliciclib | Dinaciclib |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-06-23 | ||
| $83.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-07-08 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY